Results 1 - 10 of 37

< 1 2 3 4 >

• Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis, Neurotherapeutics

  [DOI: 10.1007/s13311-015-0409-z]
  
• Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis, Molecular Neurobiology

  [DOI: 10.1007/s12035-017-0532-4]
  
• Inhibitors of Tau-Phosphorylating Kinases, Alzheimer?s Disease II

  [DOI: 10.1007/7355_2016_17]
  
• Neue Therapieprinzipien beim Pankreaskarzinom: Zweitlinientherapie/Second Line, Targeted Therapies, Erkrankungen des Pankreas

  [DOI: 10.1007/978-3-642-37964-2_74]
  
• Neuroprotective effect of masitinib in rats with postischemic stroke, Naunyn-Schmiedeberg's Archives of Pharmacology

  [DOI: 10.1007/s00210-014-1061-6]
  
• Decrease of cocaine, but not heroin, self-administration and relapse by the tyrosine kinase inhibitor masitinib in male Sprague Dawley rats, Psychopharmacology

  [DOI: 10.1007/s00213-018-4865-0]
  
• Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer, Cancer Chemotherapy and Pharmacology

  [DOI: 10.1007/s00280-010-1299-8]
  
• Neue Kinasehemmer, Zeitschrift f??r Rheumatologie

  [DOI: 10.1007/s00393-011-0880-9]
  
• Pharmacokinetics of masitinib in cats, Veterinary Research Communications

  [DOI: 10.1007/s11259-009-9231-6]
  
• Masitinib for the treatment of canine atopic dermatitis: a pilot study, Veterinary Research Communications

  [DOI: 10.1007/s11259-009-9332-2]